Biolife Solutions Inc
BLFS- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0000834365
No open-market purchases or sales by Biolife Solutions Inc insiders were filed in the last 90 days; 216 institutions reported holding it in 13F filings for Q2 2026, worth $1.40B in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Biolife Solutions Inc as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 181
- −12 vs. Q3 2024
- Shares held
- 46.8M
- +2.04M (+4.6%) vs. Q3 2024
- Total value
- $1.21B
- +$94.1M (+8.4%) vs. Q3 2024
- New holders
- 23
- 67 more added
- Sold out
- 35
- 59 more reduced
2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BLFS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 216 | $1.40B |
| Q1 2026 | 187 | $951.6M |
| Q4 2025 | 187 | $1.18B |
| Q3 2025 | 192 | $1.23B |
| Q2 2025 | 195 | $1.07B |
| Q1 2025 | 189 | $1.12B |
| Q4 2024 | 181 | $1.21B |
| Q3 2024 | 195 | $1.13B |
| Q2 2024 | 164 | $1.00B |
| Q1 2024 | 149 | $823.5M |
| Q4 2023 | 140 | $737.7M |
| Q3 2023 | 153 | $601.8M |
| Q2 2023 | 156 | $896.7M |
| Q1 2023 | 169 | $842.8M |
| Q4 2022 | 165 | $694.9M |
| Q3 2022 | 174 | $873.9M |
| Q2 2022 | 160 | $509.1M |
| Q1 2022 | 164 | $799.1M |
| Q4 2021 | 169 | $1.31B |
| Q3 2021 | 165 | $1.34B |
| Q2 2021 | 132 | $1.24B |
| Q1 2021 | 133 | $915.0M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Biolife Solutions Inc; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Atria Wealth Solutions, Inc. | 0 | $0 | 0.00% | −8,591−100.0% | Sold out |
| Quest Partners LLC | 0 | $0 | 0.00% | −2,295−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −1,556−100.0% | Sold out |
| Coppell Advisory Solutions LLC | 0 | $0 | 0.00% | −873−100.0% | Sold out |
| Danske Bank A/S | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Macroview Investment Management LLC | 0 | $0 | 0.00% | −354−100.0% | Sold out |
| Venturi Wealth Management, LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −165−100.0% | Sold out |
| Financial Network Wealth Advisors LLC | 0 | $0 | 0.00% | −42−100.0% | Sold out |
| Pineridge Advisors LLC | 0 | $0 | 0.00% | −26−100.0% | Sold out |
| Continuum Advisory, LLC | 0 | $0 | 0.00% | −29−100.0% | Sold out |
| SRS Capital Advisors, Inc. | 0 | $0 | 0.00% | −24−100.0% | Sold out |
| Ronald Blue Trust, Inc. | 0 | $0 | 0.00% | −15−100.0% | Sold out |
| Capital Performance Advisors LLP | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Massmutual Trust Co FSB | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Mendota Financial Group, LLC | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Eagle Asset Management Inc | – | – | – | – | Not filed |
| Raymond James & Associates | – | – | – | – | Not filed |